Neurocrine Biosciences to Participate at Investor Conferences in November

2024 UBS Global Healthcare Conference on November 12Stifel 2024 Healthcare Conference on November 18Jefferies London Healthcare Conference on November 19SAN DIEGO, Nov. 5, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at three upcoming investor conferences in November. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Vice-President of Investor Relations Todd Tushla will present at the 2024 UBS Global Healthcare Conference at 1:15 p.m. Pacific ...